PORTSMOUTH, N.H., Sept. 07, 2017 -- Medtronic (NYSE:MDT), a global medical device company with offices at the Pease Tradeport in Portsmouth, has been named the Best Company to Work For in New Hampshire for the fourth year in a row. The announcement was made last week by Business NH Magazine and is based on a judging process conducted with New Hampshire Businesses for Social Responsibility (NHBSR). Medtronic is featured in the magazine’s September issue, where the full list of winners appears. The company, which will be inducted into the competition’s Hall of Fame this year, will be among several other New Hampshire employers celebrated at the Breakfast with the Best event on October 19 at Grappone Conference Center in Concord.
“We’ve always celebrated our unique combination of start-up culture and big-company resources and benefits,” said Suzanne Foster, vice president and general manager of Medtronic Transformative Solutions (MTS), which is part of the Restorative Therapies Group. “Being recognized with the #1 Best Company distinction four years in a row is the best validation we can receive.”
According to the “Best Company” application, the competition looks for “the businesses whose employees love their jobs, have great benefits, are treated fairly and take pride in the work they do.” The application process includes an online engagement survey that must be completed by at least 50 percent of employees.
Foster says she takes a lot of pride in MTS’s high engagement scores. “We empower our employees to perpetuate our unique culture, and our positive survey results reflect that.” The business continues to grow its presence in New Hampshire, recently adding several new employees in Sales, R&D and Quality functions.
“Cultural fit ranks high in our recruitment process,” states Foster, “and we know the Best Company distinction will help us reach more potential employees. We appreciate Business NH Magazine and NHBSR for highlighting the businesses that focus on building the right culture for their employees.”
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 84,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Contacts: Brett Cromwell Public Relations +1-617-899-7091 Ryan Weispfenning Investor Relations +1-763-505-4626


RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Apple Turns 50: From Garage Startup to AI Crossroads
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth 



